455 related articles for article (PubMed ID: 18071079)
1. Effects of angiotensin-converting enzyme inhibition in low-risk patients early after coronary artery bypass surgery.
Rouleau JL; Warnica WJ; Baillot R; Block PJ; Chocron S; Johnstone D; Myers MG; Calciu CD; Dalle-Ave S; Martineau P; Mormont C; van Gilst WH;
Circulation; 2008 Jan; 117(1):24-31. PubMed ID: 18071079
[TBL] [Abstract][Full Text] [Related]
2. Ischemia Management with Accupril post bypass Graft via Inhibition of angiotensin coNverting enzyme (IMAGINE): a multicentre randomized trial - design and rationale.
Warnica JW; Gilst WV; Baillot R; Johnstone D; Block P; Myers MG; Chocron S; Ave SD; Martineau P; Rouleau JL
Can J Cardiol; 2002 Nov; 18(11):1191-200. PubMed ID: 12464983
[TBL] [Abstract][Full Text] [Related]
3. Sustained postoperative anaemia is associated with an impaired outcome after coronary artery bypass graft surgery: insights from the IMAGINE trial.
Westenbrink BD; Kleijn L; de Boer RA; Tijssen JG; Warnica WJ; Baillot R; Rouleau JL; van Gilst WH;
Heart; 2011 Oct; 97(19):1590-6. PubMed ID: 21757458
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibition in patients with coronary artery disease and preserved left ventricular function Ischemia Management with Accupril post-bypass graft via inhibition of angiotensin-converting enzyme (IMAGINE) compared with the other major trials in coronary artery disease.
van Gilst WH; Warnica JW; Baillot R; Johnstone D; Calciu CD; Block P; Myers MG; Chocron S; Rouleau JL;
Am Heart J; 2006 Jun; 151(6):1240-6. PubMed ID: 16781228
[TBL] [Abstract][Full Text] [Related]
5. Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study.
Chocron S; Baillot R; Rouleau JL; Warnica WJ; Block P; Johnstone D; Myers MG; Calciu CD; Nozza A; Martineau P; van Gilst WH;
Eur Heart J; 2008 Mar; 29(5):673-9. PubMed ID: 18285358
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials.
Danchin N; Cucherat M; Thuillez C; Durand E; Kadri Z; Steg PG
Arch Intern Med; 2006 Apr; 166(7):787-96. PubMed ID: 16606817
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Angiotensin-converting enzyme inhibitors and acute kidney injury after coronary artery bypass grafting.
Benedetto U; Sciarretta S; Roscitano A; Fiorani B; Refice S; Angeloni E; Sinatra R
Ann Thorac Surg; 2008 Oct; 86(4):1160-5. PubMed ID: 18805152
[TBL] [Abstract][Full Text] [Related]
8. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
[TBL] [Abstract][Full Text] [Related]
9. Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: results of the MEND-CABG randomized study.
Tardif JC; Carrier M; Kandzari DE; Emery R; Cote R; Heinonen T; Zettler M; Hasselblad V; Guertin MC; Harrington RA;
J Thorac Cardiovasc Surg; 2007 Jun; 133(6):1604-11. PubMed ID: 17532963
[TBL] [Abstract][Full Text] [Related]
10. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
Ferrari R;
Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
[TBL] [Abstract][Full Text] [Related]
12. Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery.
Kalavrouziotis D; Buth KJ; Cox JL; Baskett RJ
Am Heart J; 2011 Nov; 162(5):836-43. PubMed ID: 22093199
[TBL] [Abstract][Full Text] [Related]
13. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
[TBL] [Abstract][Full Text] [Related]
14. Impact of early coronary artery bypass graft in an unselected acute coronary syndrome patient population.
Monteiro P;
Circulation; 2006 Jul; 114(1 Suppl):I467-72. PubMed ID: 16820620
[TBL] [Abstract][Full Text] [Related]
15. β-blocker Therapy is Not Associated with Reductions in Angina or Cardiovascular Events After Coronary Artery Bypass Graft Surgery: Insights from the IMAGINE Trial.
Booij HG; Damman K; Warnica JW; Rouleau JL; van Gilst WH; Westenbrink BD
Cardiovasc Drugs Ther; 2015 Jun; 29(3):277-85. PubMed ID: 26071975
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of quinapril with high affinity for tissue angiotensin-converting enzyme after coronary intervention in Japanese.
Otsuka M; Yamamoto H; Okimoto T; Dohi Y; Mito S; Gomyo Y; Fujii T; Matsuura W; Hirai Y; Kohno N
Am Heart J; 2004 Apr; 147(4):662-8. PubMed ID: 15077082
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
[TBL] [Abstract][Full Text] [Related]
18. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC
N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219
[TBL] [Abstract][Full Text] [Related]
19. Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.
Teo KK; Mitchell LB; Pogue J; Bosch J; Dagenais G; Yusuf S;
Circulation; 2004 Sep; 110(11):1413-7. PubMed ID: 15353497
[TBL] [Abstract][Full Text] [Related]
20. The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial.
Brugts JJ; Boersma E; Chonchol M; Deckers JW; Bertrand M; Remme WJ; Ferrari R; Fox K; Simoons ML;
J Am Coll Cardiol; 2007 Nov; 50(22):2148-55. PubMed ID: 18036453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
